ResearcherUniversität UlmActive in the last 2 years
Jasmin Schuhbaur
Matched on OpenAlex author ID A5062156343. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2023: 1 paper · 2024: 1 paper
Papers 2
- Prognostic value of the CRM-status in pancreatic ductal adenocarcinoma - data from a regional cancer registry. Co-author DOI 10.1186/s12885-024-12995-z↗
- Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic canc… Co-author DOI 10.1016/j.annonc.2022.09.161↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Andrea Tannapfel · 2 shared papers, 2023–2024 · strength 0.33
- Paper Prognostic value of the CRM-status in pancreatic ductal adenocarcinoma - data from a regional cancer registry. DOI 10.1186/s12885-024-12995-z↗
- Paper Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized p… DOI 10.1016/j.annonc.2022.09.161↗
- Waldemar H. Uhl · 2 shared papers, 2023–2024 · strength 0.33
- Paper Prognostic value of the CRM-status in pancreatic ductal adenocarcinoma - data from a regional cancer registry. DOI 10.1186/s12885-024-12995-z↗
- Paper Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized p… DOI 10.1016/j.annonc.2022.09.161↗
- Thomas Theodor Werner Seufferlein · 2 shared papers, 2023–2024 · strength 0.33
- Paper Prognostic value of the CRM-status in pancreatic ductal adenocarcinoma - data from a regional cancer registry. DOI 10.1186/s12885-024-12995-z↗
- Paper Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized p… DOI 10.1016/j.annonc.2022.09.161↗
- Philipp Morakis · 1 shared paper, 2024 · strength 0.21
- Eike Gallmeier · 1 shared paper, 2023 · strength 0.12
- Michael B. Ghadimi · 1 shared paper, 2023 · strength 0.12
- Volker Kunzmann · 1 shared paper, 2023 · strength 0.12
- Thomas Jens Ettrich · 1 shared paper, 2023 · strength 0.12
- Michael Geißler · 1 shared paper, 2023 · strength 0.12
- Ingo Klein · 1 shared paper, 2023 · strength 0.12
- Detlef Klaus Bartsch · 1 shared paper, 2023 · strength 0.12
- S Daum · 1 shared paper, 2023 · strength 0.12
- Manfred Paul Lutz · 1 shared paper, 2023 · strength 0.12
- Alexander Kleger · 1 shared paper, 2023 · strength 0.12
- Anke Reinacher‐Schick · 1 shared paper, 2023 · strength 0.12
- Alexander Otto König · 1 shared paper, 2023 · strength 0.12
- Helmut Friess · 1 shared paper, 2023 · strength 0.12
- Uwe A. Wittel · 1 shared paper, 2023 · strength 0.12
- Angelika M. R. Kestler · 1 shared paper, 2023 · strength 0.12
- Margaret A. Tempero · 1 shared paper, 2023 · strength 0.12
- Hana Algül · 1 shared paper, 2023 · strength 0.12
- Marko Kornmann · 1 shared paper, 2023 · strength 0.12
- Christiane J. Bruns · 1 shared paper, 2023 · strength 0.12
- Lukas Perkhofer · 1 shared paper, 2023 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.